Clinical trial
A Multicenter, Prospective, Open and Single Arm Clinical Study of Nimotuzumab Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children
NCT04532229 is registered in ClinicalTrials.gov with Biotech Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Open and Single Arm Clinical Study of Nimotuzumab Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children
- Lead sponsor
- Biotech Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 3, 2021
- Completion date
- December 8, 2023
- Enrollment
- 48 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.